Serum potassium is a critical risk factor for cardiac arrhythmias in acute heart failure patients treated with levosimendan: A retrospective study in a cohort of 250 patients
This study identified risk factors associated with levosimendan-induced arrhythmias. Clinicians should monitor at-risk patients when administering levosimendan. When using levosimendan in clinical practice, it is necessary to maintain a serum potassium concentration above 3.94 mmol/L.
Authors
- Dong Wu (ORCID: https://orcid.org/0000-0002-7328-8207)
- Zhen Ma (ORCID: https://orcid.org/0000-0001-8650-3714)
- Bin Ning (ORCID: https://orcid.org/0000-0003-4822-716X)
- Wenguang Liu (ORCID: https://orcid.org/0000-0002-4216-2070)
- Xiaowu Wang (ORCID: https://orcid.org/0000-0003-0206-1328)
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2025-05-08
- DOI
- https://doi.org/10.5414/cp204692
- Citations
- 2
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.04